CI · CIK 1739940
What The Cigna Group told the SEC could break it.
Cigna's disclosures point first to concentration in its pharmacy-benefit business: a single pharmacy-benefit client was about 19% of total external revenue in 2025 (reported in its Evernorth segment), and U.S. Federal Government agencies have run 11–15% of external revenue. Layered on that is a financial structure that limits flexibility — roughly $31.5 billion of total debt dedicates cash flow to servicing it, while statutory rules on its insurance subsidiaries (a $4.5B minimum surplus and caps of $2.0B on dividends and $1.2B on loans to the parent without approval in 2026) restrict cash reaching the holding company. It also flags strategic-execution complexity across its pharmacy and health-care businesses, pointing to its $2.7 billion full impairment of VillageMD in 2024.
4 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- single pharmacy-benefit client ~19% of external revenue (Evernorth); U.S. Federal Government agencies 11-15%medium
Revenues from a single pharmacy-benefit client were ~19% of Cigna's total revenue from external customers in 2025 (16% in 2024), reported in Evernorth Health Services; separately, U.S. Federal Government agencies were 11% (2024) and 15% (2023) of external revenue — material client/payer concentration in the PBM business.
“Revenues from a single pharmacy benefit client were approximately 19% and 16% of total revenue from external customers for the years ended December 31, 2025 and 2024, respectively. These amounts were reported in the Evernorth Health Services segment.”
SEC filing →As of 2026
Liquidity & debt
- high leverage — ~$31.5B total indebtednessmedium
The Cigna Group's total indebtedness was ~$31.5 billion as of December 31, 2025; carrying this debt dedicates cash flow to debt service (reducing funds for operations/growth), increases vulnerability to adverse economic/industry conditions, and may limit access to capital.
“The total indebtedness of The Cigna Group was approximately $31.5 billion as of December 31, 2025.”
SEC filing →As of 2026
Regulatory & policy
- insurance-subsidiary statutory restrictions — $4.5B min surplus; $2.0B max dividend / $1.2B max parent loans without approvalmedium
Cigna's insurance subsidiaries are subject to regulatory capital constraints: $4.5B minimum statutory surplus required, $0.3B on deposit with regulators, and without regulatory approval in 2026 a maximum of $2.0B in dividend distributions and $1.2B in loans to the parent — with $11.3B of restricted GAAP net assets — limiting cash available to the holding company.
“Minimum statutory surplus required by regulators (1) $ 4.5 ... Maximum dividend distributions permitted in 2026 without regulatory approval $ 2.0 Maximum loans to the parent company permitted without regulatory approval $ 1.2 Restricted GAAP net assets of subsidiaries of The Cigna Group $ 11.3”
SEC filing →As of 2026
Other disclosures
- strategic-execution complexity across pharmacy & health-care businesses; VillageMD $2.7B impairment (2024)low
Cigna's future performance depends on executing strategic/operational initiatives whose risk is heightened by the complexity across its pharmacy-services and health-care businesses; in 2024 it recorded a $2.7B loss fully impairing its VillageMD investment, illustrating the downside of strategic bets.
“in the year ended December 31, 2024, we determined our investment in VillageMD was fully impaired and recorded a $2.7 billion loss in Net investment gains/losses ... Strategic execution risk may be heightened by the complexity across our pharmacy services and health care businesses.”
SEC filing →As of 2026
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings, including ones disclosed by the other side, which is how the non-obvious ones come to light.
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch